Mirvaso 3 mg/g Gel
PN: POMMI3
30g
This is a prescription only medicine
It is available through an NHS prescription.
Already have an existing NHS prescription?
If you already have a prescription from your GP for this medicine you can log in or register with us to place your prescription request. (There is a minimum prescription dispensing charge of £9.90 per item).
Carbomer, Methylparahydroxybenzoate (E218), Phenoxyethanol, Glycerol, Titanium Dioxide, Propylene Glycol, Sodium Hydroxide, Purified Water.
One application per 24 hours, at any time suitable for the patient, for as long as facial erythema is present. The maximum daily recommended dose is 1g in total weight. Mirvaso should be applied smoothly and evenly as a thin layer across the entire face avoiding the eyes, eyelids, lips, mouth and membrane of the inner nose. Mirvaso should only be applied over the face. Wash your hands immediately after applying.
Mirvaso can be used in conjunction with other cutaneous medicinal products for the treatment of inflammatory lesions of rosacea and with cosmetics. These products should only be applied immediately before the daily application of Mirvaso, they may be used only after the applied Mirvaso has dried.
Mirvaso can be used in conjunction with other cutaneous medicinal products for the treatment of inflammatory lesions of rosacea and with cosmetics. These products should only be applied immediately before the daily application of Mirvaso, they may be used only after the applied Mirvaso has dried.
Keep out of the reach and sight of children. Not to be used in children less than 18 years. Do not use if you are allergic to any of the listed ingredients. Do not apply to closed eyes. Mirvaso has not been studied in patients with renal or hepatic impairment. Mirvaso should not be used during pregnancy or breast feeding.
Carbomer, Methylparahydroxybenzoate (E218), Phenoxyethanol, Glycerol, Titanium Dioxide, Propylene Glycol, Sodium Hydroxide, Purified Water.
One application per 24 hours, at any time suitable for the patient, for as long as facial erythema is present. The maximum daily recommended dose is 1g in total weight. Mirvaso should be applied smoothly and evenly as a thin layer across the entire face avoiding the eyes, eyelids, lips, mouth and membrane of the inner nose. Mirvaso should only be applied over the face. Wash your hands immediately after applying.
Mirvaso can be used in conjunction with other cutaneous medicinal products for the treatment of inflammatory lesions of rosacea and with cosmetics. These products should only be applied immediately before the daily application of Mirvaso, they may be used only after the applied Mirvaso has dried.
Mirvaso can be used in conjunction with other cutaneous medicinal products for the treatment of inflammatory lesions of rosacea and with cosmetics. These products should only be applied immediately before the daily application of Mirvaso, they may be used only after the applied Mirvaso has dried.
Keep out of the reach and sight of children. Not to be used in children less than 18 years. Do not use if you are allergic to any of the listed ingredients. Do not apply to closed eyes. Mirvaso has not been studied in patients with renal or hepatic impairment. Mirvaso should not be used during pregnancy or breast feeding.